ENANTA PHARMACEUTICALS INC (ENTA) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$65.3M

Net Income/Loss (FY2025)

-$81.9M

Total Assets (FY2025)

$280.7M

Total Equity (FY2025)

$64.7M

Cash Flows from Operating Activities (FY2025)

-$19.3M

Source: ENANTA PHARMACEUTICALS INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.